Journal
NEUROLOGIC CLINICS
Volume 30, Issue 4, Pages 1389-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ncl.2012.08.018
Keywords
Psychiatric disorders; Sleep; Insomnia; Depression; Anxiety; Substance use disorders
Categories
Funding
- NIH
- Sanofi-Aventis
- Cephalon
- GlaxoSmithKline
- Merck
- Neurocrine
- Pfizer
- Sunovion/Sepracor
- Somaxon
- Takeda
- Transcept
- Phillips-Respironics
- Neurogen
- Evotec
- Kingsdown Inc
- Astellas
- Abbott
Ask authors/readers for more resources
There is growing experimental evidence that the relationship between psychiatric disorders and sleep is complex and includes bidirectional causation. This article provides the evidence that supports this point of view, reviewing data on sleep disturbances seen in patients with psychiatric disorders as well as data on the impact of sleep disturbances on psychiatric conditions. Although much has been learned about the psychiatric disorders sleep relationship, additional research is needed to better understand the relationship. Such work promises to improve comprehension of these phenomena and lead to better treatment for the many patients with sleep disorders and psychiatric disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available